Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 1:25 AM
Ignite Modification Date: 2025-12-25 @ 11:36 PM
NCT ID: NCT01854593
Description: 1 month after vitrectomy.
Frequency Threshold: 0
Time Frame: 1 month
Study: NCT01854593
Study Brief: Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic Retinopathy
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Bevacizumab and Vitrectomy 0.16mg/0.05ml bevacizumab intravitreal injection one day before surgery and vitrectomy. Bevacizumab: 0.16mg/0.05ml bevacizumab (single injection on 1 day before operation) Vitrectomy: vitrectomy of 25 gauge system. None None 0 32 0 32 View
Sham Injection and Vitrectomy Sham injection one day before operation and vitrectomy. Vitrectomy: vitrectomy of 25 gauge system. Sham injection: Sham injection one day before vitrectomy None None 0 34 0 34 View
Serious Events(If Any):
Other Events(If Any):